Copyright
©The Author(s) 2024.
World J Clin Oncol. Nov 24, 2024; 15(11): 1412-1427
Published online Nov 24, 2024. doi: 10.5306/wjco.v15.i11.1412
Published online Nov 24, 2024. doi: 10.5306/wjco.v15.i11.1412
Figure 7 The regulatory mechanism of synaptotagmin binding cytoplasmic RNA interacting protein mRNA in colorectal cancer were explored based on assay for transposase-accessible chromatin-seq and chromatin immunoprecipitation-seq.
A: Assay for transposase-accessible chromatin-seq showed the prominent enrichment in the promotor region of synaptotagmin binding cytoplasmic RNA interacting protein mRNA (SYNCRIP). And the promotor region of SYNCRIP were also enriched in chromatin immunoprecipitation-seq (ChIP-seq) with H3K4me1 and H3K27ac marked samples; B: In the POLR2A marked ChIP-seq data, the promotor region of SYNCRIP were also enriched and SYNCRIP might be regulated by POLR2A.
- Citation: Li H, Huang HQ, Huang ZG, He RQ, Fang YY, Song R, Luo JY, Zeng DT, Qin K, Wei DM, Chen G. Potential regulatory mechanism and clinical significance of synaptotagmin binding cytoplasmic RNA interacting protein in colorectal cancer. World J Clin Oncol 2024; 15(11): 1412-1427
- URL: https://www.wjgnet.com/2218-4333/full/v15/i11/1412.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i11.1412